News / All News / Article

Penguin Success | BY-HEALTH Pharmaceutical and Weiming Penguin Partner on Pharmaceutical Retail Data

Article images may contain Chinese text.

Recently, BY-HEALTH Pharmaceutical and Weiming Penguin jointly held a strategic kickoff meeting on empowering channels through digital and AI technologies, announcing an in-depth partnership in pharmaceutical retail data. Under this partnership, Weiming Penguin will provide BY-HEALTH Pharmaceutical with retail data collection, cleansing, analysis, and application services to help improve the efficiency of its channel operations and management.


At the current stage of the partnership, Weiming Penguin is using its proprietary data collection technology to efficiently collect and thoroughly cleanse vast amounts of pharmaceutical retail channel data, ensuring data accuracy and completeness. At the meeting, the two companies also discussed future directions for the partnership, expressing their hope to use AI technologies such as DeepSeek to enable efficient data applications, including intelligent data querying, and provide strong support for BY-HEALTH Pharmaceutical's business decisions.


Dai Chaowen, Deputy General Manager of BY-HEALTH Pharmaceutical, said that the company had launched a digital and AI infrastructure development and strategic upgrade program to continually improve operational effectiveness at retail outlets. Through this partnership with Weiming Penguin, the company will build data infrastructure, establish intelligent forecasting models and a data insight framework, and deeply integrate AI technologies and DeepSeek's algorithmic capabilities to enable an efficient data application model featuring 'one-click data querying and intelligent generation.' By drawing on an extensive database, it will provide precise guidance for setting operational targets, make better use of data, and energize innovation at BY-HEALTH Pharmaceutical.


Dai Chaowen further noted that he hoped the two companies could establish a lasting, collaborative innovation mechanism, pursue deeper strategic coordination in exploring digital and AI-driven operating models and intelligent applications, jointly explore further possibilities for intelligent applications, and together open a new chapter in digital and AI transformation.


Image
Image
Image


Tian Ying, Co-founder and President of Weiming Penguin, said that Weiming Penguin has always been committed to exploring and refining AI and digital capabilities for the healthcare industry, continually using AI to advance intelligent business operations built on pharmaceutical industry big data. Existing AI capabilities can efficiently support businesses across multiple scenarios, helping companies reduce costs and improve efficiency. Weiming Penguin places great importance on its partnership with BY-HEALTH Pharmaceutical and is confident about future exploration of commercial channel expansion and digital and AI-driven operating models. In the next stages of the partnership, Weiming Penguin will fully leverage its technical expertise and practical experience in digital and AI technologies, with the aim of bringing transformation and efficiency gains to BY-HEALTH Pharmaceutical and jointly taking both companies' businesses to new heights.


Following the successful conclusion of the strategic kickoff meeting, the two companies held in-depth discussions on specific project implementation details. Looking ahead, Weiming Penguin and BY-HEALTH Pharmaceutical will work together on digital and AI transformation in pharmaceutical marketing, jointly exploring and leading new industry models and approaches, bringing fresh momentum to innovation in pharmaceutical marketing, and helping the industry reach a new level.